BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21406617)

  • 1. High-throughput scintillation proximity assay for stearoyl-CoA desaturase-1.
    Tawa P; Falgueyret JP; Guiral S; Isabel E; Powell DA; Zuck P; Skorey K
    J Biomol Screen; 2011 Jun; 16(5):506-17. PubMed ID: 21406617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a high-throughput screening assay for stearoyl-CoA desaturase using rat liver microsomes, deuterium labeled stearoyl-CoA and mass spectrometry.
    Soulard P; McLaughlin M; Stevens J; Connolly B; Coli R; Wang L; Moore J; Kuo MS; LaMarr WA; Ozbal CC; Bhat BG
    Anal Chim Acta; 2008 Oct; 627(1):105-11. PubMed ID: 18790133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a novel LC/MS method to quantitate cellular stearoyl-CoA desaturase activity.
    Dillon R; Greig MJ; Bhat BG
    Anal Chim Acta; 2008 Oct; 627(1):99-104. PubMed ID: 18790132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological activity and preclinical efficacy of azetidinyl pyridazines as potent systemically-distributed stearoyl-CoA desaturase inhibitors.
    Isabel E; Powell DA; Black WC; Chan CC; Crane S; Gordon R; Guay J; Guiral S; Huang Z; Robichaud J; Skorey K; Tawa P; Xu L; Zhang L; Oballa R
    Bioorg Med Chem Lett; 2011 Jan; 21(1):479-83. PubMed ID: 21074991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel assay of cellular stearoyl-CoA desaturase activity of primary rat hepatocytes by HPLC.
    Su C; Gullberg H; Simko H; Luthman M; Edlund PO; Lundbäck T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Sep; 878(26):2427-32. PubMed ID: 20732836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel, potent, selective, and metabolically stable stearoyl-CoA desaturase (SCD) inhibitors.
    Koltun DO; Parkhill EQ; Vasilevich NI; Glushkov AI; Zilbershtein TM; Ivanov AV; Cole AG; Henderson I; Zautke NA; Brunn SA; Mollova N; Leung K; Chisholm JW; Zablocki J
    Bioorg Med Chem Lett; 2009 Apr; 19(7):2048-52. PubMed ID: 19249203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitors.
    Koltun DO; Vasilevich NI; Parkhill EQ; Glushkov AI; Zilbershtein TM; Mayboroda EI; Boze MA; Cole AG; Henderson I; Zautke NA; Brunn SA; Chu N; Hao J; Mollova N; Leung K; Chisholm JW; Zablocki J
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3050-3. PubMed ID: 19394219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stearoyl-CoA desaturase inhibitors: update on patented compounds.
    Liu G
    Expert Opin Ther Pat; 2009 Sep; 19(9):1169-91. PubMed ID: 19691439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological activity of a potent and orally bioavailable SCD inhibitor (MF-438).
    Léger S; Black WC; Deschenes D; Dolman S; Falgueyret JP; Gagnon M; Guiral S; Huang Z; Guay J; Leblanc Y; Li CS; Massé F; Oballa R; Zhang L
    Bioorg Med Chem Lett; 2010 Jan; 20(2):499-502. PubMed ID: 20004097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent, orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitors.
    Koltun DO; Zilbershtein TM; Migulin VA; Vasilevich NI; Parkhill EQ; Glushkov AI; McGregor MJ; Brunn SA; Chu N; Hao J; Mollova N; Leung K; Chisholm JW; Zablocki J
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4070-4. PubMed ID: 19577469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of 1-(4-phenoxypiperidin-1-yl)-2-arylaminoethanone stearoyl-CoA desaturase 1 inhibitors.
    Zhao H; Serby MD; Smith HT; Cao N; Suhar TS; Surowy TK; Camp HS; Collins CA; Sham HL; Liu G
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3388-91. PubMed ID: 17434733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzimidazole-carboxamides as potent and bioavailable stearoyl-CoA desaturase (SCD1) inhibitors from ligand-based virtual screening and chemical optimization.
    Matter H; Zoller G; Herling AW; Sanchez-Arias JA; Philippo C; Namane C; Kohlmann M; Pfenninger A; Voss MD
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1817-22. PubMed ID: 23395660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of potent and liver-targeted stearoyl-CoA desaturase (SCD) inhibitors in a bispyrrolidine series.
    Lachance N; Gareau Y; Guiral S; Huang Z; Isabel E; Leclerc JP; Léger S; Martins E; Nadeau C; Oballa RM; Ouellet SG; Powell DA; Ramtohul YK; Tranmer GK; Trinh T; Wang H; Zhang L
    Bioorg Med Chem Lett; 2012 Jan; 22(2):980-4. PubMed ID: 22209206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of HSCD5, a novel human stearoyl-CoA desaturase unique to primates.
    Wang J; Yu L; Schmidt RE; Su C; Huang X; Gould K; Cao G
    Biochem Biophys Res Commun; 2005 Jul; 332(3):735-42. PubMed ID: 15907797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A homogeneous scintillation proximity assay for acetyl coenzyme A carboxylase coupled to fatty acid synthase.
    Seethala R; Ma Z; Golla R; Cheng D
    Anal Biochem; 2006 Nov; 358(2):257-65. PubMed ID: 16996019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of potent and liver-selective stearoyl-CoA desaturase (SCD) inhibitors in an acyclic linker series.
    Lachance N; Guiral S; Huang Z; Leclerc JP; Li CS; Oballa RM; Ramtohul YK; Wang H; Wu J; Zhang L
    Bioorg Med Chem Lett; 2012 Jan; 22(1):623-7. PubMed ID: 22101133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of potent liver-selective stearoyl-CoA desaturase-1 (SCD1) inhibitors, thiazole-4-acetic acid derivatives, for the treatment of diabetes, hepatic steatosis, and obesity.
    Iida T; Ubukata M; Mitani I; Nakagawa Y; Maeda K; Imai H; Ogoshi Y; Hotta T; Sakata S; Sano R; Morinaga H; Negoro T; Oshida S; Tanaka M; Inaba T
    Eur J Med Chem; 2018 Oct; 158():832-852. PubMed ID: 30248655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiazole analog as stearoyl-CoA desaturase 1 inhibitor.
    Li CS; Belair L; Guay J; Murgasva R; Sturkenboom W; Ramtohul YK; Zhang L; Huang Z
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5214-7. PubMed ID: 19632834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel substituted heteroaromatic compounds as inhibitors of stearoyl-CoA desaturase.
    Dobrzyn P; Dobrzyn A
    Expert Opin Ther Pat; 2010 Jun; 20(6):849-53. PubMed ID: 20205608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput screening for N-type calcium channel blockers using a scintillation proximity assay.
    Zhang SP; Kauffman J; Yagel SK; Codd EE
    J Biomol Screen; 2006 Sep; 11(6):672-7. PubMed ID: 16831862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.